BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27109337)

  • 1. Modulation of glycine sites enhances social memory in rats using PQQ combined with d-serine.
    Zhou X; Liu D; Zhang R; Peng Y; Qin X; Mao S
    Behav Brain Res; 2016 Jul; 308():217-21. PubMed ID: 27109337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
    Shimazaki T; Kaku A; Chaki S
    Psychopharmacology (Berl); 2010 Apr; 209(3):263-70. PubMed ID: 20198471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action.
    Zhou X; Cai G; Mao S; Xu D; Xu X; Zhang R; Yao Z
    BMC Psychiatry; 2020 Mar; 20(1):106. PubMed ID: 32143671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.
    Zhou X; Chen Q; Hu X; Mao S; Kong Y
    Behav Brain Res; 2014 Jan; 258():153-9. PubMed ID: 24149067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
    Bennett S; Gronier B
    Eur J Pharmacol; 2005 Dec; 527(1-3):52-9. PubMed ID: 16307739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
    Bennett S; Gronier B
    Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sarcosine (a Glycine Transport 1 Inhibitor) and Risperidone (an Atypical antipsychotic Drug) on MK-801 Induced Learning and Memory Deficits in Rats.
    Kumar V; Ahmad MA; Najmi AK; Akhtar M
    Drug Res (Stuttg); 2016 Jan; 66(1):11-7. PubMed ID: 25710578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain.
    McCoy L; Richfield EK
    Neurosci Lett; 1996 Aug; 213(2):137-41. PubMed ID: 8858627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
    Chaki S; Shimazaki T; Karasawa J; Aoki T; Kaku A; Iijima M; Kambe D; Yamamoto S; Kawakita Y; Shibata T; Abe K; Okubo T; Sekiguchi Y; Okuyama S
    Psychopharmacology (Berl); 2015 Aug; 232(15):2849-61. PubMed ID: 25869273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
    Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.
    Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M
    Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
    Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
    Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
    Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.
    Nagai T; Takuma K; Dohniwa M; Ibi D; Mizoguchi H; Kamei H; Nabeshima T; Yamada K
    Psychopharmacology (Berl); 2007 Sep; 194(1):21-32. PubMed ID: 17514479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
    Levin ED; Petro A; Caldwell DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
    Fone KCF; Watson DJG; Billiras RI; Sicard DI; Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Mol Neurobiol; 2020 May; 57(5):2144-2166. PubMed ID: 31960362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.